Challenges in designing and running smouldering myeloma interventional clinical trials
EJHaem
.
2024 Mar 27;5(2):418-420.
doi: 10.1002/jha2.880.
eCollection 2024 Apr.
Authors
Catherine Lecat
1
,
Eileen M Boyle
1
,
Daniel Hughes
1
,
Lydia Lee
1
,
Dean Smith
2
,
Ceri Bygrave
3
,
Karthik Ramasamy
4
,
Kwee Yong
1
Affiliations
1
Department of Haematology UCL Cancer Institute London UK.
2
Department of Clinical Haematology Nottingham University Hospitals NHS Trust Nottingham UK.
3
Department of Haematology University Hospital of Wales Cardiff UK.
4
Oxford Translational Myeloma Centre, NDORMS University of Oxford Oxford UK.
PMID:
38633110
PMCID:
PMC11020121
DOI:
10.1002/jha2.880
No abstract available
Keywords:
clinical trial; multiple myeloma; precursor disease; smouldering myeloma.